Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

A Genetic Study of Psychosis in Huntington's Disease: Evidence for the Involvement of Glutamate Signaling Pathways.

Tsuang DW, Greenwood TA, Jayadev S, Davis M, Shutes-David A, Bird TD.

J Huntingtons Dis. 2018;7(1):51-59. doi: 10.3233/JHD-170277.

PMID:
29480208
2.

Genome-Wide Association Study of Psychosis Proneness in the Finnish Population.

Ortega-Alonso A, Ekelund J, Sarin AP, Miettunen J, Veijola J, Järvelin MR, Hennah W.

Schizophr Bull. 2017 Oct 21;43(6):1304-1314. doi: 10.1093/schbul/sbx006.

PMID:
28525603
3.

Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine.

Taylor DL, Tiwari AK, Lieberman JA, Potkin SG, Meltzer HY, Knight J, Remington G, Müller DJ, Kennedy JL.

Mol Neuropsychiatry. 2017 Feb;2(4):185-197. doi: 10.1159/000449224. Epub 2016 Oct 12.

4.

Sensorimotor gating deficits are inheritable in an isolation-rearing paradigm in rats.

Ko CY, Wang SC, Liu YP.

Behav Brain Res. 2016 Apr 1;302:115-21. doi: 10.1016/j.bbr.2016.01.008. Epub 2016 Jan 8.

PMID:
26778785
5.

Common variants in SLC1A2 and schizophrenia: Association and cognitive function in patients with schizophrenia and healthy individuals.

Zhang B, Guan F, Chen G, Lin H, Zhang T, Feng J, Li L, Fu D.

Schizophr Res. 2015 Dec;169(1-3):128-134. doi: 10.1016/j.schres.2015.10.012. Epub 2015 Oct 12.

PMID:
26459047
6.

Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia.

Afshari P, Myles-Worsley M, Cohen OS, Tiobech J, Faraone SV, Byerley W, Middleton FA.

Mol Neuropsychiatry. 2015 Oct;1(3):125-44. doi: 10.1159/000433599. Epub 2015 Jul 8.

7.

Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia.

O'Donovan SM, Hasselfeld K, Bauer D, Simmons M, Roussos P, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE.

Transl Psychiatry. 2015 Jun 9;5:e579. doi: 10.1038/tp.2015.74.

8.

Association of rare variation in the glutamate receptor gene SLC1A2 with susceptibility to bipolar disorder and schizophrenia.

Fiorentino A, Sharp SI, McQuillin A.

Eur J Hum Genet. 2015 Sep;23(9):1200-6. doi: 10.1038/ejhg.2014.261. Epub 2014 Nov 19.

9.

Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness.

Kaur H, Jajodia A, Grover S, Baghel R, Jain S, Kukreti R.

Am J Med Genet B Neuropsychiatr Genet. 2014 Dec;165B(8):635-46. doi: 10.1002/ajmg.b.32268. Epub 2014 Sep 11.

PMID:
25209194
10.

Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia.

Spangaro M, Bosia M, Zanoletti A, Bechi M, Mariachiara B, Pirovano A, Lorenzi C, Bramanti P, Smeraldi E, Cavallaro R.

Pharmacogenomics. 2014 May;15(7):925-32. doi: 10.2217/pgs.14.42.

PMID:
24956246
11.

Dopamine denervation of the prefrontal cortex increases expression of the astrocytic glutamate transporter GLT-1.

Vollbrecht PJ, Simmler LD, Blakely RD, Deutch AY.

J Neurochem. 2014 Jul;130(1):109-14. doi: 10.1111/jnc.12697. Epub 2014 Mar 18.

12.

Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia.

Shan D, Mount D, Moore S, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE.

Schizophr Res. 2014 Apr;154(1-3):1-13. doi: 10.1016/j.schres.2014.01.028. Epub 2014 Feb 21.

13.

Effect of glutamate transporter EAAT2 gene variants and gray matter deficits on working memory in schizophrenia.

Poletti S, Radaelli D, Bosia M, Buonocore M, Pirovano A, Lorenzi C, Cavallaro R, Smeraldi E, Benedetti F.

Eur Psychiatry. 2014 May;29(4):219-25. doi: 10.1016/j.eurpsy.2013.07.003. Epub 2013 Sep 26.

PMID:
24076156
14.

Forebrain gene expression predicts deficits in sensorimotor gating after isolation rearing in male rats.

Swerdlow NR, Light GA, Trim RS, Breier MR, Hines SR, Powell SB.

Behav Brain Res. 2013 Nov 15;257:118-28. doi: 10.1016/j.bbr.2013.09.005. Epub 2013 Sep 25.

15.

Coupling of gene expression in medial prefrontal cortex and nucleus accumbens after neonatal ventral hippocampal lesions accompanies deficits in sensorimotor gating and auditory processing in rats.

Swerdlow NR, Powell SB, Breier MR, Hines SR, Light GA.

Neuropharmacology. 2013 Dec;75:38-46. doi: 10.1016/j.neuropharm.2013.06.003. Epub 2013 Jun 26.

16.

Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia.

Spangaro M, Bosia M, Zanoletti A, Bechi M, Cocchi F, Pirovano A, Lorenzi C, Bramanti P, Benedetti F, Smeraldi E, Cavallaro R.

Neurosci Lett. 2012 Aug 1;522(2):151-5. doi: 10.1016/j.neulet.2012.06.030. Epub 2012 Jun 21.

PMID:
22728822
17.

Overstimulation of NMDA receptors impairs early brain development in vivo.

Aida T, Ito Y, Takahashi YK, Tanaka K.

PLoS One. 2012;7(5):e36853. doi: 10.1371/journal.pone.0036853. Epub 2012 May 11.

18.

Ethanol and phencyclidine interact with respect to nucleus accumbens dopamine release: differential effects of administration order and pretreatment protocol.

Pickering C, Chau PP, Söderpalm B, Ericson M.

Front Behav Neurosci. 2010 Jun 10;4:32. doi: 10.3389/fnbeh.2010.00032. eCollection 2010.

19.

Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia.

Bauer D, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE.

Schizophr Res. 2010 Mar;117(1):92-8. doi: 10.1016/j.schres.2009.07.025. Epub 2009 Aug 27.

20.

No genetic association between the SLC1A2 gene and Japanese patients with schizophrenia.

Nagai Y, Ohnuma T, Karibe J, Shibata N, Maeshima H, Baba H, Hatano T, Hanzawa R, Arai H.

Neurosci Lett. 2009 Oct 9;463(3):223-7. doi: 10.1016/j.neulet.2009.07.092. Epub 2009 Aug 4.

PMID:
19660525

Supplemental Content

Loading ...
Support Center